Beneficial effects of long-term enalapril treatment and low-salt intake on survival rate of Dahl salt-sensitive rats with established hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 625-629

  Kodama, Kohtarou ^a   Adachi, Hideyuki ^a   Sonoda, Jiro ^a  

^a EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; GLOMERULOSCLEROSIS; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; ENALAPRIL; HEART RATE; HYPERTENSION; KIDNEY; MALE; RATS; SODIUM CHLORIDE, DIETARY; SURVIVAL RATE;

EID: 0030815880     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ANDERSON, P. W., Do, Y. S. AND HSUEH, W. A.: Angiotensin II causes mesangial cell hypertrophy. Hypertension 21: 29-35, 1993.
2. BÖHM, M., MORANO, I., PIESKE, B., RÜEGG, J. C., WANKERL, M., ZIMMERMANN, R. AND ERDMANN, E.: Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ. Res. 68: 689-701, 1991.
3. DE SIMONE, G., DEVEREUX, R. B., CAMARGO, M. J. F., WALLERSON, D. C., SEALEY, J. E. AND LARAGH, J. H.: Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. Am. J. Hypertens. 9: 216-222, 1996.
4. FLECKENSTEIN, A., FLECKENSTEIN-GRÜN, G., FREY, M. AND ZORN, J.: Future directions in the use of calcium antagonists. Am. J. Cardiol. 59: 177B-187B, 1987.
5. INOKO, M., KIHARA, Y., MORII, I., FUJIWARA, H. AND SASAYAMA, S.: Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am. J. Physiol. 267: H2471-H2482, 1994.
6. KITAGAWA, S., YAMAGUCHI, Y., SHINOZUKA, K., KWON, Y. M. AND KUNITOMO, M.: Dietary cholesterol enhances impaired endothelium-dependent relaxations in aortas of salt-induced hypertensive Dahl rats. Eur. J. Pharmacol. 297: 71-76, 1996.
7. KNORR, A., GARTHOFF, B., KAZDA, S. AND STASCH, J. P.: Effects of different antihypertensive drug classes on survival in animal models. J. Cardiovasc. Pharmacol. 17: Suppl. 2, S94-S100, 1991.
8. LEE, R. M. K. W. AND TRIGGLE, C. R.: Morphometric study of mesenteric arteries from genetically hypertensive Dahl strain rats. Blood Vessels 23: 199-224, 1986.
9. LUCKHAUS, G., GARTHOFF, B. AND KAZDA, S.: Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats. Arzneim.-Forsch./Drug Res. 32: 1421-1425, 1982.
10. PELAYO, J. C., QUAN, A. H. AND SHANLEY, P. F.: Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am. J. Physiol. 258: F414-F422, 1990.
11. PFEFFER, M. A., PFEFFER, J., MIRSKY, I. AND IWAI, J.: Cardiac hypertrophy and performance of Dahl hypertensive rats on graded salt diets. Hypertension 6: 475-481, 1984.
12. RAIJ, L., AZAR, S. AND KEANE, W.: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26: 137-143, 1984.
13. SIMCHON, S., MANGER, W. M., CARLIN, R. D., PEETERS, L. L., RODRIGUETZ, J., BATISTA, D., BROWN, T., MERCHANT, N. B., JAN, K.-M. AND CHIEN, S.: Salt-induced hypertension in Dahl salt-sensitive rats. Hypertension 13: 612-621, 1989.
14. STERZEL, R. B., LUFT, F. C., GAO, Y., SCHNERMANN, J., BRIGGS, J. P., GANTEN, D., WALDHERR, R., SCHNABEL, E. AND KRIZ, W.: Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int. 33: 1119-1129, 1988.
15. STIER, C. T. JR., BENTER, I. F., AHMAD, S., Zuo, H., SELIG, N., ROETHEL, S., LEVINE, S. AND ITSKOVITZ, H. D.: Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13: 115-121, 1989.
16. THE CONSENSUS TRIAL STUDY GROUP: Effects of enalapril on mortality in severe congestive heart failure. N. Engl. J. Med. 316: 1429-1435, 1987.
17. THE SOLVD INVESTIGATORS: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325: 293-302, 1991.
18. UEHARA, Y., NUMABE, A., HIRAWA, N., KAWABATA, Y., IWAI, J., ONO, H., MATSUOKA, H., TAKABATAKE, Y., YAGI, S. AND SUGIMOTO, T.: Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. J. Hypertens. 9: 719-728, 1991.
19. UNGER, T., GANTEN, D., LANG, R. E. AND SCHÖLKENS, B. A.: Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 7: 36-41, 1985.
20. VON LUTTEROTTI, N., CAMARGO, M. J. F., CAMPBELL, W. G. JR., MUELLER, F. B., TIMMERMANS, P. B., SEALEY, J. E. AND LARAGH, J. H.: Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J. Hypertens. 10: 949-957, 1992.